Organogenesis Holdings Inc
Healthcare · EUR · F
Price
€2.261
Cap
€304.96M
Earnings
—
30d Trend
+11.4%
60% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 52×Macro 0.99 (−1%)=51
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
12-24 month value thesis — fundamentally underpriced
BRAIN47'S ASSESSMENT
I rate Organogenesis Holdings Inc at 51/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is fundamentals at 90/100. I classify this as a speculative position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
+13.9%
3 MONTHS
-18.4%
12 MONTHS
-8.1%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
12-24 month value thesis — fundamentally underpriced. Fundamentals (90) and Quality (57) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 60%. I classify this as a speculative position — elevated volatility at 60% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.